2017 Fiscal Year Final Research Report
Therapeutic drug monitoring of patients with psoriasis during tumour necrosis factor (TNF)-a antagonist treatment using a novel interleukin-8 reporter cell line
Project/Area Number |
15K09754
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Dermatology
|
Research Institution | Tohoku University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
相場 節也 東北大学, 医学系研究科, 教授 (80159269)
|
Project Period (FY) |
2015-10-21 – 2018-03-31
|
Keywords | 乾癬 / TNF-a阻害剤 / ルシフェラーゼアッセイ / インターロイキン-8 / 薬物動態 / THP-1 / 生物学的製剤 |
Outline of Final Research Achievements |
There was a significant correlation between change in PASI and inhibitory rate of TNF-a induced IL-8 promoter activity. Therapeutic monitoring of patients with psoriasis during TNF-a antagonist therapy using IL-8 reporter cell line, THP-G8 can provide a useful tool to determine objectively the efficacy of the administered TNF-a antagonists. Furthermore, using IL-2 reporter cell line, several drugs including JAK inhibitors inhibited IL-2 promoter activity.
|
Free Research Field |
皮膚科学
|